CoChat

Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Abstract

Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system and can cause various types of pain including ongoing extremity pain, Lhermitte's phenomenon, trigeminal neuralgia, and mixed pain. Neuropathic pain is a major concern for individuals with multiple sclerosis as it is directly linked to myelin damage in the central nervous system and the management of neuropathic pain in multiple sclerosis is challenging as the options available have limited efficacy and can cause unpleasant side effects. The literature search was conducted across two databases, PubMed, and Google Scholar. Eligible studies included clinical trials, observational studies, meta-analyses, systematic reviews, and narrative reviews. The objective of this article is to provide an overview of literature on pharmacological and non-pharmacological strategies employed in the management of neuropathic pain in multiple sclerosis. Pharmacological options include cannabinoids, muscle relaxants (tizanidine, baclofen, dantrolene), anticonvulsants (benzodiazepines, gabapentin, phenytoin, carbamazepine, lamotrigine), antidepressants (duloxetine, venlafaxine, tricyclic antidepressants), opioids (naltrexone), and botulinum toxin variants, which have evidence from various clinical trials. Non-pharmacological approaches for trigeminal neuralgia may include neurosurgical methods. Non-invasive methods, physical therapy, and psychotherapy (cognitive behavioral therapy, acceptance and commitmen…

Overview

Integrity signals

Registry

Crossref · 10.1007/s40263-024-01072-5

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Research works printed but not linked: 4

  1. Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group. Neurology. 1994;44:S34–42 (discussion S42–3).
  2. Belousov AN, Belousova EY, Lekomtseva YV. Prospects for the application of nanotechnology in the treatment of multiple sclerosis. Int J Clin Med Case Rep. 2023;2:1–8. https://doi.org/10.31579/2834-8664/017. · doi:10.31579/2834-8664/017
  3. Boiko DI, Kachur RV, Ajala OM, Bodnar LA, Zhyvotovska LV. Characteristics of anxiety and depressive manifestations in patients with acute myocardial infarction taking into account their personal accentuations. Azerbaijan Med J. 2021;2:25–31. https://doi.org/10.34921/amj.2021.2.004. · doi:10.34921/amj.2021.2.004
  4. Hasanpour DA. Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial. J Sports Med Phys Fitness. 2016;56:1417–22.

Cited by

See all 31

Metadata

Authors
Shkodina, A. D., Bardhan, M., Chopra, H., Anyagwa, O. E., Pinchuk, V. A., Hryn, K. V., Kryvchun, A. M., Boiko, D. I., Suresh, V., Verma, A., & Delva, M. Y.
Affiliations
  • Poltava State Medical University (UA)
  • Baptist Hospital of Miami (US)
  • Saveetha University (IN)
  • New Vision University (GE)
  • King George's Medical University (IN)
Corresponding author
Bardhan, Mainak
Venue
CNS Drugs
Published
2024-02-29
Volume
38
Issue
3
Pages
205-224
ISSN
  • 1172-7047 (ISSN-L)
  • 1179-1934
OpenAlex
W4392293990
Cited by
31
References
188
Citations by year
2026: 8 · 2025: 17 · 2024: 6
FWCI
2.31
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Funders
Poltava State Medical University (0120U104165, 0121U108235)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
multiple sclerosis, neuropathic pain, trigeminal neuralgia, mixed pain, cannabinoids, muscle relaxants, antiepileptic drugs, antidepressants, opioids, botulinum toxin, non-pharmacological treatment, cognitive behavioral therapy, acceptance and commitment therapy, mindfulness-based stress reduction, physiotherapy, neurosurgery
MeSH terms
Anticonvulsants, Antidepressive Agents, Humans, Multiple Sclerosis, Neuralgia, Trigeminal Neuralgia, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.